SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-16-535334
Filing Date
2016-04-08
Accepted
2016-04-08 15:13:10
Documents
8

Document Format Files

Seq Description Document Type Size
1 424B4 d49718d424b4.htm 424B4 1464368
2 GRAPHIC g49718g06s19.jpg GRAPHIC 39265
3 GRAPHIC g49718g09p36.jpg GRAPHIC 78333
4 GRAPHIC g49718g28q83.jpg GRAPHIC 53483
5 GRAPHIC g49718g31u81.jpg GRAPHIC 54120
6 GRAPHIC g49718g59o17.jpg GRAPHIC 69210
7 GRAPHIC g49718g68c24.jpg GRAPHIC 94886
8 GRAPHIC g49718g68m32.jpg GRAPHIC 15066
  Complete submission text file 0001193125-16-535334.txt   2023248
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-208182 | Film No.: 161562517
SIC: 2834 Pharmaceutical Preparations